Stock Research for STML

STML

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

STML Stock Chart & Research Data

The STML chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the STML chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


STML Due diligence Resources & Stock Charts

The STML stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View STML Detailed Price Forecast - CNN Money CNN View STML Detailed Summary - Google Finance
Yahoo View STML Detailed Summary - Yahoo! Finance Zacks View STML Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View STML Trends & Analysis - Trade-Ideas Barrons View STML Major Holders - Barrons
NASDAQ View STML Call Transcripts - NASDAQ Seeking View STML Breaking News & Analysis - Seeking Alpha
Spotlight View STML Annual Report - CompanySpotlight.com OTC Report View STML OTC Short Report - OTCShortReport.com
TradeKing View STML Fundamentals - TradeKing Charts View STML SEC Filings - Bar Chart
WSJ View Historical Prices for STML - The WSJ Morningstar View Performance/Total Return for STML - Morningstar
MarketWatch View the Analyst Estimates for STML - MarketWatch CNBC View the Earnings History for STML - CNBC
StockMarketWatch View the STML Earnings - StockMarketWatch MacroAxis View STML Buy or Sell Recommendations - MacroAxis
Bullish View the STML Bullish Patterns - American Bulls Short Pains View STML Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View STML Stock Mentions - StockTwits PennyStocks View STML Stock Mentions - PennyStockTweets
Twitter View STML Stock Mentions - Twitter Invest Hub View STML Investment Forum News - Investor Hub
Yahoo View STML Stock Mentions - Yahoo! Message Board Seeking Alpha View STML Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for STML - SECform4.com Insider Cow View Insider Transactions for STML - Insider Cow
CNBC View STML Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for STML - OTC Markets
Yahoo View Insider Transactions for STML - Yahoo! Finance NASDAQ View Institutional Holdings for STML - NASDAQ


Stock Charts

FinViz View STML Stock Insight & Charts - FinViz.com StockCharts View STML Investment Charts - StockCharts.com
BarChart View STML Stock Overview & Charts - BarChart Trading View View STML User Generated Charts - Trading View




Latest Financial News for STML


Read This Before Buying Stemline Therapeutics, Inc. (NASDAQ:STML) Shares
Posted on Monday January 21, 2019

We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The flip side of that is that there are more Read More...


Stemline Therapeutics Closes $92 Million Public Offering of Common Stock
Posted on Friday January 18, 2019

Stemline Therapeutics, Inc. (STML), a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing innovative oncology therapeutics, today announced the closing of a previously announced underwritten public offering of 10,222,222 shares of its common stock, which included the exercise in full of the option to purchase 1,333,333 additional shares, at a price of $9.00 per share. J.P. Morgan Securities LLC and Cowen and Company, LLC acted as joint book-running managers for the offering. Cantor Fitzgerald & Co., Ladenburg Thalmann & Co. Inc. and H.C. Wainwright & Co., LLC acted as co-lead managers and Roth Capital Partners, LLC, ThinkEquity, a division of Fordham Financial Management, Inc., A.G.P./Alliance Global Partners, National Securities Corporation, and Aegis Capital Corp. acted as co-managers for the offering.


Stemline Therapeutics (STML) in Focus: Stock Moves 9.5% Higher
Posted on Wednesday January 16, 2019

Stemline Therapeutics (STML) shares rose nearly 10% in the last trading session, amid huge volumes.


Stemline Therapeutics Announces Upsizing and Pricing of $80 Million Public Offering of Common Stock
Posted on Tuesday January 15, 2019

Stemline Therapeutics, Inc. (STML), a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing innovative oncology therapeutics, today announced the pricing of an underwritten public offering of 8,888,889 shares of its common stock at a price of $9.00 per share, with expected gross proceeds to Stemline of $80 million. Stemline has also granted the underwriters a 30-day option to purchase up to 1,333,333 additional shares of its common stock at the public offering price, less underwriting discounts and commissions. Cantor Fitzgerald & Co., Ladenburg Thalmann & Co. Inc. and H.C. Wainwright & Co., LLC are acting as co-lead managers and Roth Capital Partners, LLC, ThinkEquity, a division of Fordham Financial Management, Inc., A.G.P./Alliance Global Partners, National Securities Corporation, and Aegis Capital Corp. are acting as co-managers for the offering.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.